ライフサイエンスコーパス: skin cancer

1 ents developed cancer (excluding nonmelanoma skin cancer).

2 hnique for non-Hodgkin lymphoma and melanoma skin cancer.

3 rmatology clinic underwent biopsy to exclude skin cancer.

4 the sun's UV radiation is a leading cause of skin cancer.

5 ard, kappa, 0.41-0.63), for the diagnosis of skin cancer.

6 to most effectively predict the incidence of skin cancer.

7 for solar ultraviolet (UV) radiation-induced skin cancer.

8 Melanoma is the most aggressive type of skin cancer.

9 rcinoma (cSCC) is the most common metastatic skin cancer.

10 physical appearance and risk of keratinocyte skin cancer.

11 rare and aggressive, yet highly immunogenic skin cancer.

12 lation of mutations and an increased risk of skin cancer.

13 is associated with the risks of cataract and skin cancer.

14 cataract in left eyes and left-sided facial skin cancer.

15 erkel cell carcinoma (MCC), a lethal form of skin cancer.

16 ous history of cancer other than nonmelanoma skin cancer.

17 lieved that people with dark skin cannot get skin cancer.

18 and have a very high incidence of UV-induced skin cancer.

19 splant recipients have a higher incidence of skin cancer.

20 in those considered to be at higher risk for skin cancer.

21 biquitous carcinogen in sunlight that causes skin cancer.

22 ]) wanted to learn more about how to prevent skin cancer.

23 for the chemoprevention and therapy against skin cancer.

24 l proportion can progress into squamous cell skin cancer.

25 cipients (OTRs) are at an increased risk for skin cancer.

26 Melanoma is a lethal form of skin cancer.

27 ded by AICDA) links chronic inflammation and skin cancer.

28 lts aged 18 to 60 years without a history of skin cancer.

29 ous HSCT recipients had no increased risk of skin cancer.

30 ase in incidence of melanoma and nonmelanoma skin cancer.

31 ad to strategies for preventing and treating skin cancer.

32 lts aged 18 to 60 years without a history of skin cancer.

33 hat tomato consumption would protect against skin cancer.

34 NER protects against skin cancer.

35 Cutaneous melanoma (CM) is the most lethal skin cancer.

36 presents the identification of the deadliest skin cancer.

37 are highly expressed in human patients with skin cancer.

38 melanoma (MM) is the most aggressive form of skin cancer.

39 are considered potential early precursors of skin cancer.

40 ase in incidence of melanoma and nonmelanoma skin cancer.

41 g adulthood, increase the risk of developing skin cancer.

42 ntial therapeutic targets in this metastatic skin cancer.

43 and sunburn and thus prevent future cases of skin cancer.

44 233 benign meningiomas, and 1856 nonmelanoma skin cancers.

45 improving the chemotherapeutic efficiency of skin cancers.

46 t malignancies, meningiomas, and nonmelanoma skin cancers.

47 nt lesions will permit us to prevent or cure skin cancers.

48 y of the biodegradable nanogels for treating skin cancers.

49 dependent manner and was detectable in human skin cancers.

50 mination yielded a higher absolute number of skin cancers.

51 ncer, which has the highest mortality of all skin cancers.

52 Malignant melanoma is the deadliest of skin cancers.

53 idence, we estimated 5- and 10-year risks of skin cancers.

54 ant cancers, of which 115 cases (88.5%) were skin cancers.

55 gher risk of all-site, urothelial, lung, and skin cancers.

56 bedrock and tool of choice for the study of skin cancers.

57 s for prevention or treatment of UVR-induced skin cancers.

58 hair development, hair growth disorders, and skin cancers.

59 gy in clinical practice for the diagnosis of skin cancer?

60 1.4%] vs 8 [36.4%]) and knowing the signs of skin cancer (11 [25.0%] vs 10 [45.4%]).

61 otal, 1982 individuals were screened, and 47 skin cancers (2.4%) were histologically confirmed, inclu

62 ] vs 19 [6.1%] answered yes), and history of skin cancer (76 [33.3%] vs 15 [4.8%] answered yes) (all

63 Among those reporting no prior history of skin cancer, a similar model with 10 factors predicted k

64 ll carcinoma (cuSCC) comprises 15-20% of all skin cancers, accounting for over 700,000 cases in USA a

65 ortance: Keratinocyte carcinoma (nonmelanoma skin cancer) accounts for substantial burden in terms of

66 The high risk of skin cancer after organ transplantation is a major clini

67 cell polyomavirus (MCV) causes an aggressive skin cancer after prolonged infection and requires an ac

68 The course of skin cancer after retransplantation in organ-transplant

69 of organ transplanted, time to diagnosis of skin cancer after transplantation, and history of condyl

70 nts in the genesis of many cancers including skin cancer and are often implicated in tumor progressio

71 an ultraviolet radiation (UV)-induced human skin cancer and from a mouse model of urethane-induced c

72 l carcinoma (BCC) is the most common type of skin cancer and is usually nonpigmented.

73 Melanoma is the most lethal form of skin cancer and successful treatment of metastatic melan

74 lear for all main cancers except nonmelanoma skin cancer and was stronger for cancers of poorer progn

75 rmatologist after 33 (53.2%) for presumptive skin cancers and 15 (24.2%) for precancers.

76 .2%; 4 of 27 patients [14.8%] diagnosed with skin cancers and 5 of 11 patients [45.5%] diagnosed with

77 A causal link between UV-independent skin cancers and chronic inflammation has been suspected

78 DLX3 expression is lost in human skin cancers and is extinguished during progression of e

79 Two nonmelanoma skin cancers and two major adverse cardiovascular events

80 for age, sex, educational level, history of skin cancer, and history of AK.

81 ly history of melanoma, previous nonmelanoma skin cancer, and lifetime sunbed use.

82 ther skin phenotypes such as acne, color and skin cancers are also being investigated with GWAS.

83 cer (subhazard ratio, 2.1; 95% CI, 1.2-3.7), skin cancer as the index posttransplant cancer (subhazar

84 Merkel cell carcinoma is a rare skin cancer associated with Merkel cell polyomavirus in

85 s the deadliest form of commonly encountered skin cancer because of its rapid progression towards met

86 To compare the risk of skin cancer between transplant recipients and background

87 evelopment of prostate cancer, colon cancer, skin cancer, breast cancer, lung cancer and pancreas can

88 d lung; malignant skin melanoma; nonmelanoma skin cancer; breast; cervical; uterine; ovarian; prostat

89 Surgeon General's Call to Action to Prevent Skin Cancer broadly identified research gaps, but specif

90 nt recipients carry a substantial measurable skin cancer burden at any given time and require frequen

91 transplant recipients is well-known, but the skin cancer burden at any one time is unknown.

92 Organ transplant recipients with the highest skin cancer burden were Australian born, were fair skinn

93 ncer prevention and, therefore, decrease the skin cancer burden.

94 well established than those for other common skin cancers, but recent evidence has highlighted a pote

95 on may increase the risk of solar UV-induced skin cancer by promoting photochemical damage to the NER

96 yV10) among controls from a population-based skin cancer case-control study (n = 460) conducted in Ne

97 rt that NFAT3 is highly expressed in various skin cancer cell lines and tumor tissues.

98 chitosan for ionic interaction with anionic skin cancer cell membrane.

99 roven melanomas in 134 patients treated in 9 skin cancer centers in Spain, France, Italy, and Austria

100 ylated NFAT3-Ser259 were highly expressed in skin cancer compared with normal skin tissues.

101 aft failure in recipients with pretransplant skin cancer compared with those without cancer.

102 hether its use leads to earlier detection of skin cancer compared with usual care.

103 vioral research addressing all points of the skin cancer control continuum, measuring interventions t

104 eceiving treatment of a condition other than skin cancer (controls) at the dermatology clinics at the

105 the pump-probe signals from melanin in human skin cancers correlate well with clinical concern, but i

106 ystem, we found that brain, lung, colon, and skin cancers could be detected in situ during surgery wi

107 The skin cancer detection rate per 100 participants did not

108 oscopy (RCM) improves diagnostic accuracy in skin cancer detection when combined with dermoscopy; how

109 key areas of medical diagnostics, breast and skin cancer detection.

110 Most skin cancers develop as the result of UV light-induced D

111 Calcipotriol suppressed skin cancer development in mice in a TSLP-dependent mann

112 inflammation-induced AID expression promotes skin cancer development independently of UV damage and s

113 Factors associated with subsequent skin cancer development were evaluated via multivariate

114 ons: (1) How accurate is teledermatology for skin cancer diagnosis compared with usual care (face-to-

115 tive and specific for non-invasively guiding skin cancer diagnosis.

116 Skin cancer education and intervention efforts in uninsu

117 s: The influence of the screening program on skin cancer epidemiological findings and the cost per qu

118 The influence of the screening program on skin cancer epidemiological findings and the cost per qu

119 ess their budget effect and the influence on skin cancer epidemiological findings.

120 ess their budget effect and the influence on skin cancer epidemiological findings.

121 hat will reduce the likelihood of developing skin cancer, especially melanoma.

122 rs with the strongest effects were >20 prior skin cancers excised (odds ratio 8.57, 95% confidence in

123 who at baseline reported no past history of skin cancer excisions and no more than five destructivel

124 ed information on skin, hair, and eye color; skin cancer family history; and sun exposure history, su

125 and 1.71 (95% CI, 0.88-3.33) for nonmelanoma skin cancers for survivors with reference characteristic

126 Independent predictors of skin cancer formation after the index posttransplant can

127 These same risk factors were associated with skin cancer formation when the analysis was limited to n

128 n of positive section margins in nonmelanoma skin cancer from 8.4% to 12.8%.

129 n of positive section margins in nonmelanoma skin cancer from 8.4% to 12.8%.

130 The number of excisions needed to detect 1 skin cancer from clinical visual skin examinations varie

131 Recipients with pretransplant skin cancer had increased risk of PTM (sub-HR [SHR], 2.6

132 The risk for skin cancer has been well characterized in white organ t

133 eases in the United States, the incidence of skin cancer has important public health consequences, in

134 ts who have already developed posttransplant skin cancer has not been assessed.

135 h or substantial morbidity, whereas melanoma skin cancer has notably higher mortality rates.

136 oma, and lung, pancreatic, and nonepithelial skin cancers (higher during function intervals), and kid

137 in patients with and without a pretransplant skin cancer history was 31.6% and 7.4%, respectively (P

138 rived separate models within strata of prior skin cancer history, age, and sex.

139 ractices that further increase their risk of skin cancer; however, gaps in the literature exist in yo

140 represent the vast majority of all cases of skin cancer; however, they rarely result in death or sub

141 ransplant skin cancer included pretransplant skin cancer (HR, 4.69; 95% CI, 3.26-6.73), male sex (HR,

142 3.4; 95% CI, 2.0 to 6.0), and nonepithelial skin cancers (HR, 3.8; 95% CI, 2.5 to 5.8).

143 ning sign of progression toward non-melanoma skin cancer, if ignored.

144 kin examination by a clinician to screen for skin cancer in adults (I statement).

145 lid-organ transplant recipients, the risk of skin cancer in hematopoietic stem-cell transplant (HSCT)

146 Prostate cancer is the most common non-skin cancer in males, with a approximately 1.5-2-fold hi

147 n the use of sirolimus for the prevention of skin cancer in nonrenal OTRs or those already diagnosed

148 ic and clinical factors and the incidence of skin cancer in nonwhite organ transplant recipients.

149 Skin cancer in nonwhite patients is associated with grea

150 ies have demonstrated a reduced incidence of skin cancer in renal OTRs treated with sirolimus.

151 s research has reported an increased risk of skin cancer in solid organ transplant recipients (OTRs),

152 ecipients with histopathologically confirmed skin cancer in the 3-month baseline period was estimated

153 udy in efforts to better counsel and prevent skin cancer in these patients.

154 Most skin cancers in Asians were located on sun-exposed areas

155 k of squamous cell carcinoma (SCC) and other skin cancers in organ transplant recipients (OTRs), but

156 keratinocyte cancers (KCs) overall and other skin cancers in relation to azathioprine treatment.

157 Nonmelanoma skin cancers, in particular cutaneous squamous cell carc

158 The increased skin cancer incidence in organ transplant recipients is

159 significant risk factors for posttransplant skin cancer included pretransplant skin cancer (HR, 4.69

160 Importance: Rates of skin cancer, including basal cell carcinoma (BCC), the m

161 evaluate the risk factors for posttransplant skin cancer, including squamous cell carcinoma (SCC), me

162 olonged exposure, but the incidence of other skin cancers increases.

163 al role in UV-induced immune suppression and skin cancer induction.

164 Posttransplant skin cancer is common, with elevated risk imparted by in

165 he risk factors and trends in posttransplant skin cancer is fundamental to targeted screening and pre

166 Skin cancer is most common in XP-C, XP-E, and XP-V patie

167 d in OTRs who develop cancer if the risk for skin cancer is of concern.

168 Skin cancer is the most common malignancy occurring afte

169 Skin cancer is the most frequent cancer type.

170 The main risk factor for skin cancer is ultraviolet (UV) exposure, which causes D

171 While a high risk of nonmelanoma skin cancer is well recognized in solid-organ transplant

172 ions in South Asia, but its association with skin cancers is as yet unknown.

173 Melanoma, the most aggressive form of skin cancer, is often fatal if not treated early.

174 of sun/UV exposure-related illness, such as skin cancer, is seriously concerning public health autho

175 -induced DNA damage, a major risk factor for skin cancers, is primarily repaired by nucleotide excisi

176 Nonmelanoma skin cancer, Kaposi sarcoma, and posttransplant lymphopr

177 Melanoma, one of the deadliest forms of skin cancer, kills nearly 10,000 people in the United St

178 onship between sunburn and risk of different skin cancers (melanoma, squamous cell carcinoma (SCC), a

179 related deaths, especially for the deadliest skin cancer, melanoma.

180 clinical visual skin examination in reducing skin cancer morbidity and mortality and death from any c

181 , adults, and parents, with an aim to reduce skin cancer morbidity and mortality.

182 and is predicted to result in a reduction of skin cancer mortality over 20 years and 50 years.

183 inoma (SCC) in QSkin, a prospective study of skin cancer (N = 43,794).

184 s across the United States in the Transplant Skin Cancer Network during 1 of 2 calendar years (either

185 ffects of UV-B radiation against nonmelanoma skin cancer (NMSC) are exerted via signaling mechanisms

186 reviewed the DSCMs for residual nonmelanoma skin cancer (NMSC) before and after a brief training ses

187 atients with a periocular region nonmelanoma skin cancer (NMSC) or a nonperiocular NMSC causing a com

188 or any incident cancer excluding nonmelanoma skin cancer (NMSC) were 1.06 (95% CI, 1.02-1.09), 1.06 (

189 k than HIV-uninfected persons of nonmelanoma skin cancer (NMSC), defined as basal cell carcinoma (BCC

190 ing Mohs micrographic surgery of nonmelanoma skin cancer (NMSC), inflammation in histologic frozen se

191 suppression is a risk factor for nonmelanoma skin cancer (NMSC), particularly squamous cell tumors.

192 billing codes and categorized as nonmelanoma skin cancer (NMSC), viral-linked and "other" cancers.

193 increases the risk of developing nonmelanoma skin cancers (NMSCs).

194 ss all three trials, adjudicated nonmelanoma skin cancer occurred in five patients who received tofac

195 V radiation (UVR)-induced skin pigmentation, skin cancers, ocular surface disease, and, in some patie

196 referrals overall and those for presumptive skin cancer or actinic keratoses, skin biopsies, or PCP

197 ost a quarter (49 [24.5%) had never heard of skin cancer or melanoma.

198 in biopsies, and PCP diagnostic accuracy for skin cancer or precancer compared with dermatologist dia

199 ignant melanoma is one of the most dangerous skin cancer originating from melanocytes.

200 t public health consequences, including poor skin cancer outcomes, in part because of late-stage diag

201 Secondary endpoints included the course of skin cancers over 3 periods (first transplantation, retu

202 The incidence rates for posttransplant skin cancer overall and for SCC, MM, and MCC were calcul

203 skin diseases, hyperpigmentation, psoriasis, skin cancer, pachyonychia congenital) caused by aberrant

204 To study temporal trends for the risk of skin cancer, particularly SCC, after organ transplantati

205 liquid biopsies from brain, breast, lung and skin cancer patients were classified in 2.4 cumulative s

206 splant recipients are at risk for developing skin cancer posttransplantation.

207 ing NLRP1 to skin inflammatory syndromes and skin cancer predisposition.

208 ence interval = [1.07, 2.43]), reported past skin cancer (prevalence ratio =3.39, 95% confidence inte

209 e behavior that can help reduce the risk for skin cancer, prevent sunburns, mitigate photoaging, and

210 Objective: To characterize skin cancer prevention and education needs in uninsured,

211 of SASP expression may offer new targets for skin cancer prevention and therapy.

212 r tanning frequency and behaviors related to skin cancer prevention and to investigate whether these

213 r tanning frequency and behaviors related to skin cancer prevention and to investigate whether these

214 importance of sun protection and facilitate skin cancer prevention and, therefore, decrease the skin

215 re, it is important to identify obstacles in skin cancer prevention in these communities.

216 lusions and Relevance: Important barriers to skin cancer prevention were lack of knowledge, the belie

217 Sun-protective behavior affects skin cancer prevention.

218 Skin cancer, primarily melanoma, is a leading cause of m

219 d incision-defective XPG mutations cause the skin cancer-prone syndrome xeroderma pigmentosum.

220 against loss of bone mass, chronic diseases, skin cancer, prostate cancer, and cardiovascular disease

221 ted with an increased risk of posttransplant skin cancer, PTLD, solid organ cancer, death and graft f

222 tudied the association between pretransplant skin cancer, PTM, death, and graft failure.

223 en compared with the number of biopsy-proven skin cancers recorded over a similar period before the f

224 Grant success rate in skin cancer-related behavioral science compares favorabl

225 l Institute of Health (NIH) grants targeting skin cancer-related behaviors and relevant outcomes.

226 ant applications from 2000 to 2014 targeting skin cancer-related behaviors or testing behavioral inte

227 morbidities and mortalities associated with skin cancers requires sustained research with the goal o

228 s Follow-up Study (1992-2010) to investigate skin cancer risk associated with history of severe sunbu

229 Little is known about cutaneous disease and skin cancer risk in this OTR population.

230 , Spanish, or Haitian Creole assessing their skin cancer risk perception, knowledge, sun protective b

231 An 11.6% reduction in skin cancer risk was observed in the sirolimus-treated v

232 atric clinics and decrease children's future skin cancer risk.

233 e existing literature on sunburn history and skin cancer risk.

234 severe sunburns at different body sites with skin cancer risk.

235 ing the approach to the analysis of over 200 skin cancer samples, we demonstrate its utility for disc

236 limited evidence on the association between skin cancer screening and mortality.

237 mplementation of a campaign promoting annual skin cancer screening by FBSE, including training of PCP

238 oma deaths in a region with population-based skin cancer screening compared with no change or slight

239 is critical to emphasize sun protection and skin cancer screening in individuals who tan indoors.

240 The cost-effectiveness for skin cancer screening is higher in women than in men.

241 Skin cancer screening may improve melanoma outcomes and

242 the cost-effectiveness of 2 population-based skin cancer screening methods and to assess their budget

243 the cost-effectiveness of 2 population-based skin cancer screening methods and to assess their budget

244 particularly regarding potential benefit of skin cancer screening on melanoma mortality.

245 nting to 1 dermatologist for melanoma and/or skin cancer screening or surveillance.

246 are payer perspective) of 2 population-based skin cancer screening programs in Belgium compared with

247 are payer perspective) of 2 population-based skin cancer screening programs in Belgium compared with

248 To describe a skin cancer screening quality initiative in a large heal

249 Future research on skin cancer screening should focus on evaluating the eff

250 Only limited evidence was identified for skin cancer screening, particularly regarding potential

251 to sunburn, avoid sun protection, and avoid skin cancer screening.

252 to sunburn, avoid sun protection, and avoid skin cancer screening.

253 ive Services Task Force for population-based skin cancer screening.

254 2.60; 95% CI, 2.27-2.98), and posttransplant skin cancer (SHR, 2.92; 95% CI, 2.52-3.39), PTLD (SHR, 1

255 the highest and moderate risk of developing skin cancer (skin types I, II, III, and IV) than in skin

256 osttransplant malignancy was classified into skin cancer, solid tumor, and posttransplant lymphoproli

257 nscriptional repressor, is down-modulated in skin cancer stromal cells, and Atf3 knockout mice develo

258 nsplant cancer were history of pretransplant skin cancer (subhazard ratio, 2.1; 95% CI, 1.2-3.7), ski

259 Although a causative element in skin cancers, sunlight is also associated with positive

260 6 outcomes (mean difference of 0.5 or more): skin cancer, surgical complications, cognition, blood pr

261 tients appear to be much less susceptible to skin cancer than other XP groups.

262 Merkel-cell carcinoma is an aggressive skin cancer that is linked to exposure to ultraviolet li

263 Nonmelanoma skin cancers that required at least 3 Mohs micrographic

264 Skin cancer, the most common human malignancy, is primar

265 Although highly expressed in normal skin and skin cancer, the role of the atypical E2Fs, E2F7 and E2F

266 ge and suggest AID as a potential target for skin cancer therapeutics.

267 tial as a novel target for the prevention of skin cancer through its role in the regulation of STAT3

268 f video-mosaics of melanoma and non-melanoma skin cancers, to demonstrate potential clinical utility.

269 but little is known about the feasibility of skin cancer training and clinical skin examination (CSE)

270 This pilot study suggests that PCP-based skin cancer training and screening are feasible and have

271 To assess the association of skin cancer training and screening by PCPs with dermatol

272 city, Fitzpatrick type, type and location of skin cancer, type of organ transplanted, time to diagnos

273 ed based on age, sex, history of nonmelanoma skin cancer, US geographic region, and population densit

274 igand status is associated with keratinocyte skin cancers using a population-based study of basal cel

275 The incidence rates for posttransplant skin cancer was 1437 per 100000 person-years.

276 Risk of skin cancer was analyzed using standardized incidence ra

277 Pretransplant skin cancer was associated with an increased risk of pos

278 Incident skin cancer was determined through detailed medical reco

279 Skin cancer was diagnosed in 64 (41.6%) white OTRs and 1

280 Nonmelanoma skin cancer was not observed among irradiated NHBs, and

281 incidence of spontaneous tumors, especially skin cancer, was observed in adult BMT-rescued DNA-PKcs(

282 nalysis, age, sex, and previous diagnosis of skin cancer were not significantly associated with the p

283 Potential risk factors for posttransplant skin cancer were tested using multivariate Cox regressio

284 Nineteen skin cancers were identified in 15 patients (5.8%) repre

285 Biopsy-proven skin cancers were recorded for 16 months (for patient 1)

286 ce of all-type cancer (excluding nonmelanoma skin cancers), which was evaluated using Kaplan-Meier su

287 noma constitutes the most aggressive form of skin cancer, which further metastasizes into a deadly fo

288 Melanoma is a pigmented type of skin cancer, which has the highest mortality of all skin

289 or head and neck, genitalia, hands, and feet skin cancers, which may represent an additional financia

290 imers (CPDs) are DNA photoproducts linked to skin cancer, whose mutagenicity depends in part on their

291 idence on the effectiveness of screening for skin cancer with a clinical visual skin examination in r

292 e to assess the net benefit of screening for skin cancer with a clinical visual skin examination is l

293 tificial intelligence capable of classifying skin cancer with a level of competence comparable to der

294 Melanoma is the most deadly form of skin cancer with a yearly global incidence over 232,000

295 Merkel cell carcinoma is a rare, aggressive skin cancer with poor prognosis in patients with advance

296 (MCC) is a highly aggressive neuroendocrine skin cancer with profound but poorly understood resistan

297 (cSCC) is one of the most common metastatic skin cancers with increasing incidence.

298 rapy, melanoma remains the deadliest form of skin cancer, with a 5-year survival rate of only 15%.

299 e counseled more effectively on the signs of skin cancer, with focused discussion points contingent o

300 er had a lower risk of developing subsequent skin cancer, with no increased risk for overall mortalit